APA (7th ed.) Citation

Cheifetz, A. S., Allegretti, J. R., Quintas, M., Dixit, B., Farquhar, R., Miller, B. W., . . . Stevens, A. (2025). Small-Molecule Neutrophil Modulator ADS051 is Safe and Well-Tolerated in a Phase 1 Single Ascending Dose Study. American Journal of Gastroenterology (Lippincott Williams & Wilkins), 120(7), 1585. https://doi.org/10.14309/ajg.0000000000003237

Chicago Style (17th ed.) Citation

Cheifetz, Adam S., et al. "Small-Molecule Neutrophil Modulator ADS051 Is Safe and Well-Tolerated in a Phase 1 Single Ascending Dose Study." American Journal of Gastroenterology (Lippincott Williams & Wilkins) 120, no. 7 (2025): 1585. https://doi.org/10.14309/ajg.0000000000003237.

MLA (9th ed.) Citation

Cheifetz, Adam S., et al. "Small-Molecule Neutrophil Modulator ADS051 Is Safe and Well-Tolerated in a Phase 1 Single Ascending Dose Study." American Journal of Gastroenterology (Lippincott Williams & Wilkins), vol. 120, no. 7, 2025, p. 1585, https://doi.org/10.14309/ajg.0000000000003237.